Short Interest in Exicure, Inc. (NASDAQ:XCUR) Decreases By 34.8%

Exicure, Inc. (NASDAQ:XCUR) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 61,200 shares, a drop of 34.8% from the November 30th total of 93,900 shares. Based on an average daily trading volume, of 725,400 shares, the short-interest ratio is presently 0.1 days. Currently, 5.6% of the company’s stock are short sold.

Exicure Price Performance

Shares of NASDAQ:XCUR opened at $17.58 on Friday. The stock has a market capitalization of $45.81 million, a P/E ratio of -8.49 and a beta of 3.66. The business has a 50-day moving average of $12.57 and a two-hundred day moving average of $5.22. Exicure has a fifty-two week low of $1.44 and a fifty-two week high of $36.00.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.